IHRA, developed by Aarca Research, revolutionizes early detection of metabolic conditions such as Type 2 Diabetes, Hypertension, and Dyslipidemia. Using proprietary software and a third-party thermal camera, IHRA provides risk scores that are crucial for early intervention and management.
Safe and non-invasive metabolic health risk assessment using thermal imaging.
Delivers risk scores in real-time, aiding swift decision-making.
Assesses multiple conditions simultaneously to provide a holistic view of metabolic health.
Using proprietary software and a third-party thermal camera, IHRA provides risk scores that are crucial for early intervention and management.
Utilises medical thermal imaging with advanced data analytics.
Leverages proprietary software and integrates seamlessly into diverse health systems.
Provides detailed reports outlining individual risk scores for targeted conditions.
Early Detection
Empowers physicians with the information needed to prevent the progression.
Patient Convenience
Simplifies the health assessment process, requiring minimal patient preparation and no physical discomfort.
Enhanced Healthcare Delivery
Enables more effective population health management through scalable screenings.
IHRA has undergone extensive clinical trials, proving its efficacy and accuracy in early risk assessment. It's recognized by healthcare professionals for its innovative approach to preventive health. Our publications
Our comorbidity report contains a scale of 0-10 that shows severity of the indicators along with conclusions and next steps for each condition. Users can use this report and approach a dietician and/or a medical professional to get detailed prevention and treatment plan. This screening is not a substitute for a regular physical examination by your healthcare provider.
NerveVue delivers an innovative, non-invasive solution for the early detection of Peripheral Artery Disease (PAD), driving earlier intervention, improved outcomes, and cost efficiency across the continuum of care.
We are extending our heartfelt appreciation for your exceptional dedication and success in
conducting the IHRA pilot project for non-invasive screening of Type 2 Diabetes, Hypertension, and
Dyslipidemia at KEM Hospital. Your hard work has yielded remarkable results and insights, reaffirming our
commitment to innovative healthcare solutions.
Your collaborative approach and unwavering focus on improving healthcare are inspiring. This will provide
us with the opportunity to build upon the accomplishments of the pilot and continue our pursuit of
meaningful advancements in patient care.
Thank you for your valuable contributions.
The method and screening conducted by the Aarca Research team using a thermal camera are unique and we have come across such technology for the first time. The reports and results published by your team is matching with the health condition of the individuals. We also received positive feedback from the team and the individuals who attended this camp and completed the screenings. We are sure all your endeavours in the coming years will lead to demonstrating more of such commendable initiatives.
IHRA is an effective and reliable solution for the early detection of metabolic comorbidities such as Type II Diabetes, Hypertension and Dyslipidemia. IHRA can be used as a screening tool for the early detection of the onset of these conditions and to inform the healthcare personnel for further investigations. IHRA has the potential for widespread improvement in clinical outcomes and for deployment in large public health programs across communities.
We have done more than 500 people's screening with this product in less than 3 days. It is quick, accurate and innovative. It's a good concept to know the health issues. Encourages our teams to be proactive about their health. Highly recommended.
This method is non-invasive and quick. Face scan using the thermal camera is a powerful innovation to conduct health checks. With this proven accuracy and ease of use, we envision this to be used for health checks for our clients.
Our metabolic health applications are designed to identify risks early, track key biomarkers, and provide organizations with the tools to support healthier lifestyles.
